# FDA 483 - Alexander E. Horwitz, III, M.D. - November 14, 2014

Source: https://www.keypedia.com/records/483/alexander-e-horwitz-iii-md/0e6473f6-a651-438e-a7e2-dea9f1df76f2

> FDA 483 for Alexander E. Horwitz, III, M.D. on November 14, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Alexander E. Horwitz, III, M.D.
- Inspection Date: 2014-11-14
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West VI
- Summary: An FDA inspection of Oregon Center of Clinical Investigations revealed significant deficiencies in the conduct of a clinical investigation. The firm failed to adhere to the investigational plan, including enrolling ineligible subjects and not promptly reporting protocol deviations or adverse events to the sponsor. Additionally, inaccuracies were found in the maintenance of case histories.

## Related Officers

- [investigator](https://www.keypedia.com/people/sherri-n-rohlf/41090ab1-83d1-4e95-92ea-0cfca5cecdb6)

Company: https://www.keypedia.com/companies/alexander-e-horwitz-iii-md/86082505-bbcc-4f38-977e-ab37b9551fe1

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-vi/6e5a2a08-f464-4979-a759-7b0383370822